{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:23:00Z","timestamp":1790191380561,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To characterise pancreatic cancer cells from different sources which are used as model systems to study the metastatic behaviour in pancreatic ductal adenocarcinoma (PDAC), we compared the <jats:italic>N<\/jats:italic>-glycan imprint of four PDAC cells which were previously shown to differ in their galectin-4 expression and metastatic potential <jats:italic>in vivo<\/jats:italic>. Next to the sister cell lines Pa-Tu-8988S and Pa-Tu-8988T, which were isolated from the same liver metastasis of a PDAC, this included two primary PDAC cell cultures, PDAC1 and PDAC2. Additionally, we extended the <jats:italic>N<\/jats:italic>-glycan profiling to a normal, immortalized pancreatic duct cell line. Our results revealed major differences in the <jats:italic>N<\/jats:italic>-glycosylation of the different PDAC cells as well as compared to the control cell line, suggesting changes of the <jats:italic>N<\/jats:italic>-glycosylation in PDAC. The <jats:italic>N-<\/jats:italic>glycan profiles of the PDAC cells, however, differed vastly as well and demonstrate the diversity of PDAC model systems, which ultimately affects the interpretation of functional studies. The results from this study form the basis for further biological evaluation of the role of protein glycosylation in PDAC and highlight that conclusions from one cell line cannot be generalised, but should be regarded in the context of the corresponding phenotype.<\/jats:p>","DOI":"10.1038\/s41598-017-16811-6","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T10:40:11Z","timestamp":1511520011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-0428","authenticated-orcid":false,"given":"Stephanie","family":"Holst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Belo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"van Die","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-4995","authenticated-orcid":false,"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"16811_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA: a cancer journal for clinicians \n                           66, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21332 (2016).","journal-title":"CA: a cancer journal for clinicians"},{"key":"16811_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0039-6109(05)70143-2","volume":"81","author":"AM Cooperman","year":"2001","unstructured":"Cooperman, A. M. PANCREATIC CANCER: The Bigger Picture. Surgical Clinics of North America \n                           81, 557\u2013574, https:\/\/doi.org\/10.1016\/S0039-6109(05)70143-2 (2001).","journal-title":"Surgical Clinics of North America"},{"key":"16811_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mc.20785","volume":"51","author":"C Bosetti","year":"2012","unstructured":"Bosetti, C. et al. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog \n                           51, 3\u201313, https:\/\/doi.org\/10.1002\/mc.20785 (2012).","journal-title":"Mol Carcinog"},{"key":"16811_CR4","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff, J. et al. Pancreatic cancer. Nat Rev Dis Primers \n                           2, 16022, https:\/\/doi.org\/10.1038\/nrdp.2016.22 (2016).","journal-title":"Nat Rev Dis Primers"},{"key":"16811_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1245\/s10434-011-1900-3","volume":"19","author":"JM Winter","year":"2012","unstructured":"Winter, J. M. et al. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Annals of surgical oncology \n                           19, 169\u2013175, https:\/\/doi.org\/10.1245\/s10434-011-1900-3 (2012).","journal-title":"Annals of surgical oncology"},{"key":"16811_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan, D. P., Hong, T. S. & Bardeesy, N. Pancreatic adenocarcinoma. The New England journal of medicine \n                           371, 1039\u20131049, https:\/\/doi.org\/10.1056\/NEJMra1404198 (2014).","journal-title":"The New England journal of medicine"},{"key":"16811_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature \n                           531, 47\u201352, https:\/\/doi.org\/10.1038\/nature16965 (2016).","journal-title":"Nature"},{"key":"16811_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/pin.12114","volume":"64","author":"Y Saiki","year":"2014","unstructured":"Saiki, Y. & Horii, A. Molecular pathology of pancreatic cancer. Pathol Int \n                           64, 10\u201319, https:\/\/doi.org\/10.1111\/pin.12114 (2014).","journal-title":"Pathol Int"},{"key":"16811_CR9","first-page":"11683","volume":"8","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. International journal of clinical and experimental medicine \n                           8, 11683\u201311691 (2015).","journal-title":"International journal of clinical and experimental medicine"},{"key":"16811_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/jclinpath-2014-202451","volume":"68","author":"D Reitz","year":"2015","unstructured":"Reitz, D. et al. Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer. Journal of clinical pathology \n                           68, 427\u2013433, https:\/\/doi.org\/10.1136\/jclinpath-2014-202451 (2015).","journal-title":"Journal of clinical pathology"},{"key":"16811_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/pr8007013","volume":"8","author":"C Li","year":"2009","unstructured":"Li, C. et al. Pancreatic cancer serum detection using a lectin\/glyco-antibody array method. Journal of proteome research \n                           8, 483\u2013492, https:\/\/doi.org\/10.1021\/pr8007013 (2009).","journal-title":"Journal of proteome research"},{"key":"16811_CR12","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1021\/pr400967x","volume":"13","author":"S Nie","year":"2014","unstructured":"Nie, S. et al. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. Journal of proteome research \n                           13, 1873\u20131884, https:\/\/doi.org\/10.1021\/pr400967x (2014).","journal-title":"Journal of proteome research"},{"key":"16811_CR13","doi-asserted-by":"publisher","unstructured":"Takahashi, S. et al. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer. Glycoconjugate journal, https:\/\/doi.org\/10.1007\/s10719-016-9653-7 (2016).","DOI":"10.1007\/s10719-016-9653-7"},{"key":"16811_CR14","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/cncr.26490","volume":"118","author":"Y Takeda","year":"2012","unstructured":"Takeda, Y. et al. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer \n                           118, 3036\u20133043, https:\/\/doi.org\/10.1002\/cncr.26490 (2012).","journal-title":"Cancer"},{"key":"16811_CR15","doi-asserted-by":"publisher","first-page":"e65957","DOI":"10.1371\/journal.pone.0065957","volume":"8","author":"AI Belo","year":"2013","unstructured":"Belo, A. I., van der Sar, A. M., Tefsen, B. & van Die, I. Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells. PLoS One \n                           8, e65957, https:\/\/doi.org\/10.1371\/journal.pone.0065957 (2013).","journal-title":"PLoS One"},{"key":"16811_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02890431","volume":"61","author":"HP Elsasser","year":"1992","unstructured":"Elsasser, H. P., Lehr, U., Agricola, B. & Kern, H. F. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol \n                           61, 295\u2013306 (1992).","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"16811_CR17","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.18632\/oncotarget.2104","volume":"5","author":"M Maftouh","year":"2014","unstructured":"Maftouh, M. et al. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt\/beta-catenin signalling in pancreatic adenocarcinoma. Oncotarget \n                           5, 5335\u20135349, https:\/\/doi.org\/10.18632\/oncotarget.2104 (2014).","journal-title":"Oncotarget"},{"key":"16811_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1074\/mcp.M115.051235","volume":"15","author":"S Holst","year":"2016","unstructured":"Holst, S. et al. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)\/Villin mRNA Expression. Molecular & cellular proteomics: MCP \n                           15, 124\u2013140, https:\/\/doi.org\/10.1074\/mcp.M115.051235 (2016).","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"16811_CR19","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1021\/pr5011718","volume":"14","author":"Y Hu","year":"2015","unstructured":"Hu, Y. et al. N-linked glycan profiling in neuroblastoma cell lines. Journal of proteome research \n                           14, 2074\u20132081, https:\/\/doi.org\/10.1021\/pr5011718 (2015).","journal-title":"Journal of proteome research"},{"key":"16811_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jprot.2014.05.002","volume":"108","author":"JH Chik","year":"2014","unstructured":"Chik, J. H. et al. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. Journal of proteomics \n                           108, 146\u2013162, https:\/\/doi.org\/10.1016\/j.jprot.2014.05.002 (2014).","journal-title":"Journal of proteomics"},{"key":"16811_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/btpr.92","volume":"25","author":"PH van Berkel","year":"2009","unstructured":"van Berkel, P. H. et al. N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG. Biotechnol Prog \n                           25, 244\u2013251, https:\/\/doi.org\/10.1002\/btpr.92 (2009).","journal-title":"Biotechnol Prog"},{"key":"16811_CR22","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-13-0837","volume":"73","author":"A Avan","year":"2013","unstructured":"Avan, A. et al. Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. Cancer Res \n                           73, 6745\u20136756, https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0837 (2013).","journal-title":"Cancer Res"},{"key":"16811_CR23","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1021\/ac500335t","volume":"86","author":"KR Reiding","year":"2014","unstructured":"Reiding, K. R., Blank, D., Kuijper, D. M., Deelder, A. M. & Wuhrer, M. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Analytical chemistry \n                           86, 5784\u20135793, https:\/\/doi.org\/10.1021\/ac500335t (2014).","journal-title":"Analytical chemistry"},{"key":"16811_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.carres.2015.04.019","volume":"413","author":"HM Park","year":"2015","unstructured":"Park, H. M. et al. Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. Carbohydrate research \n                           413, 5\u201311, https:\/\/doi.org\/10.1016\/j.carres.2015.04.019 (2015).","journal-title":"Carbohydrate research"},{"key":"16811_CR25","doi-asserted-by":"publisher","unstructured":"Loke, I., Kolarich, D., Packer, N. H. & Thaysen-Andersen, M. Emerging roles of protein mannosylation in inflammation and infection. Mol Aspects Med, https:\/\/doi.org\/10.1016\/j.mam.2016.04.004 (2016).","DOI":"10.1016\/j.mam.2016.04.004"},{"key":"16811_CR26","doi-asserted-by":"crossref","unstructured":"Holst, S., Wuhrer, M. & Rombouts, Y. in Advances in cancer research Vol. 126 (eds R. Drake Richard & E. Ball Lauren) 203\u2013256 (Academic Press, 2015).","DOI":"10.1016\/bs.acr.2014.11.004"},{"key":"16811_CR27","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.biocel.2013.05.015","volume":"45","author":"M P\u00e9rez-Garay","year":"2013","unstructured":"P\u00e9rez-Garay, M. et al. \u03b12,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. The International Journal of Biochemistry & Cell Biology \n                           45, 1748\u20131757, https:\/\/doi.org\/10.1016\/j.biocel.2013.05.015 (2013).","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"16811_CR28","doi-asserted-by":"publisher","first-page":"e98595","DOI":"10.1371\/journal.pone.0098595","volume":"9","author":"S Bassaganas","year":"2014","unstructured":"Bassaganas, S. et al. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of alpha2beta1 integrin and E-cadherin function. PLoS One \n                           9, e98595, https:\/\/doi.org\/10.1371\/journal.pone.0098595 (2014).","journal-title":"PLoS One"},{"key":"16811_CR29","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.3748\/wjg.v21.i13.3876","volume":"21","author":"N Terao","year":"2015","unstructured":"Terao, N. et al. Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes. World journal of gastroenterology: WJG \n                           21, 3876\u20133887, https:\/\/doi.org\/10.3748\/wjg.v21.i13.3876 (2015).","journal-title":"World journal of gastroenterology: WJG"},{"key":"16811_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fonc.2016.00093","volume":"6","author":"A Natoni","year":"2016","unstructured":"Natoni, A., Macauley, M. S. & O\u2019Dwyer, M. E. Targeting Selectins and Their Ligands in Cancer. Frontiers in oncology \n                           6, 93, https:\/\/doi.org\/10.3389\/fonc.2016.00093 (2016).","journal-title":"Frontiers in oncology"},{"key":"16811_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00006676-199107000-00012","volume":"6","author":"Y Satomura","year":"1991","unstructured":"Satomura, Y. et al. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues. Pancreas \n                           6, 448\u2013458 (1991).","journal-title":"Pancreas"},{"key":"16811_CR32","first-page":"475","volume":"48","author":"YS Kim","year":"1988","unstructured":"Kim, Y. S. et al. Lex and Ley antigen expression in human pancreatic cancer. Cancer Res \n                           48, 475\u2013482 (1988).","journal-title":"Cancer Res"},{"key":"16811_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10719-008-9207-8","volume":"26","author":"J Mitoma","year":"2009","unstructured":"Mitoma, J. et al. The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells. Glycoconjugate journal \n                           26, 511\u2013523, https:\/\/doi.org\/10.1007\/s10719-008-9207-8 (2009).","journal-title":"Glycoconjugate journal"},{"key":"16811_CR34","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0006-291X(03)00086-X","volume":"301","author":"KM Lee","year":"2003","unstructured":"Lee, K. M., Nguyen, C., Ulrich, A. B., Pour, P. M. & Ouellette, M. M. Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochemical and biophysical research communications \n                           301, 1038\u20131044 (2003).","journal-title":"Biochemical and biophysical research communications"},{"key":"16811_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/17460440902821657","volume":"4","author":"G Feldmann","year":"2009","unstructured":"Feldmann, G., Rauenzahn, S. & Maitra, A. In vitro models of pancreatic cancer for translational oncology research. Expert Opin Drug Discov \n                           4, 429\u2013443, https:\/\/doi.org\/10.1517\/17460440902821657 (2009).","journal-title":"Expert Opin Drug Discov"},{"key":"16811_CR36","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/cbin.10137","volume":"37","author":"MI Maqsood","year":"2013","unstructured":"Maqsood, M. I., Matin, M. M., Bahrami, A. R. & Ghasroldasht, M. M. Immortality of cell lines: challenges and advantages of establishment. Cell Biol Int \n                           37, 1038\u20131045, https:\/\/doi.org\/10.1002\/cbin.10137 (2013).","journal-title":"Cell Biol Int"},{"key":"16811_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/10.1007\/s10616-004-5123-3","volume":"45","author":"KM Lee","year":"2004","unstructured":"Lee, K. M., Choi, K. H. & Ouellette, M. M. Use of exogenous hTERT to immortalize primary human cells. Cytotechnology \n                           45, 33\u201338, https:\/\/doi.org\/10.1007\/10.1007\/s10616-004-5123-3 (2004).","journal-title":"Cytotechnology"},{"key":"16811_CR38","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.febslet.2015.07.035","volume":"589","author":"AI Belo","year":"2015","unstructured":"Belo, A. I. et al. Hypoxia inducible factor 1alpha down regulates cell surface expression ofalpha1,2-fucosylated glycans in human pancreatic adenocarcinoma cells. FEBS Lett \n                           589, 2359\u20132366, https:\/\/doi.org\/10.1016\/j.febslet.2015.07.035 (2015).","journal-title":"FEBS Lett"},{"key":"16811_CR39","first-page":"1449","volume":"60","author":"M Aubert","year":"2000","unstructured":"Aubert, M. et al. Restoration of \u03b1(1,2) Fucosyltransferase Activity Decreases Adhesive and Metastatic Properties of Human Pancreatic Cancer Cells. Cancer research \n                           60, 1449\u20131456 (2000).","journal-title":"Cancer research"},{"key":"16811_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.0.CO;2-T","volume":"71","author":"H Ito","year":"1997","unstructured":"Ito, H. et al. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. International journal of cancer. Journal international du cancer \n                           71, 556\u2013564 (1997).","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"16811_CR41","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1073\/pnas.92.12.5724","volume":"92","author":"J Sun","year":"1995","unstructured":"Sun, J. et al. Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proceedings of the National Academy of Sciences of the United States of America \n                           92, 5724\u20135728 (1995).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"16811_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/mas.20337","volume":"30","author":"M Wuhrer","year":"2011","unstructured":"Wuhrer, M., Deelder, A. M. & van der Burgt, Y. E. M. Mass spectrometric glycan rearrangements. Mass Spectrometry Reviews \n                           30, 664\u2013680, https:\/\/doi.org\/10.1002\/mas.20337 (2011).","journal-title":"Mass Spectrometry Reviews"},{"key":"16811_CR43","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1158\/0008-5472.CAN-08-0289","volume":"69","author":"T Satomaa","year":"2009","unstructured":"Satomaa, T. et al. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res \n                           69, 5811\u20135819, https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0289 (2009).","journal-title":"Cancer Res"},{"key":"16811_CR44","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ajpath.2011.05.025","volume":"179","author":"WM Hsu","year":"2011","unstructured":"Hsu, W. M. et al. B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via beta(1) integrin signaling in neuroblastoma. The American journal of pathology \n                           179, 1394\u20131404, https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.025 (2011).","journal-title":"The American journal of pathology"},{"key":"16811_CR45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/1541-7786.MCR-06-0431","volume":"5","author":"J Huang","year":"2007","unstructured":"Huang, J. et al. Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. Molecular cancer research: MCR \n                           5, 543\u2013552, https:\/\/doi.org\/10.1158\/1541-7786.MCR-06-0431 (2007).","journal-title":"Molecular cancer research: MCR"},{"key":"16811_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fonc.2016.00055","volume":"6","author":"S Mereiter","year":"2016","unstructured":"Mereiter, S., Balmana, M., Gomes, J., Magalhaes, A. & Reis, C. A. Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer. Frontiers in oncology \n                           6, 55, https:\/\/doi.org\/10.3389\/fonc.2016.00055 (2016).","journal-title":"Frontiers in oncology"},{"key":"16811_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/rcm.3444","volume":"22","author":"M Strohalm","year":"2008","unstructured":"Strohalm, M., Hassman, M., Kosata, B. & Kodicek, M. mMass data miner: an open source alternative for mass spectrometric data analysis. Rapid communications in mass spectrometry: RCM \n                           22, 905\u2013908, https:\/\/doi.org\/10.1002\/rcm.3444 (2008).","journal-title":"Rapid communications in mass spectrometry: RCM"},{"key":"16811_CR48","doi-asserted-by":"crossref","unstructured":"Jansen, B. C., Reiding, K. R., Bondt, A., Hipgrave Ederveen, A.L., Palmblad, M., Falck, D., Wuhrer, M. MassyTools: A high throughput targeted data processing tool for relative quantitation and quality control developed for glycomic and glycoproteomic MALDI-MS. Journal of proteome research (2015).","DOI":"10.1021\/acs.jproteome.5b00658"},{"key":"16811_CR49","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/pmic.200900804","volume":"10","author":"LR Ruhaak","year":"2010","unstructured":"Ruhaak, L. R., Steenvoorden, E., Koeleman, C. A., Deelder, A. M. & Wuhrer, M. 2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics \n                           10, 2330\u20132336, https:\/\/doi.org\/10.1002\/pmic.200900804 (2010).","journal-title":"Proteomics"},{"key":"16811_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/expr.2000.4573","volume":"96","author":"AK Nyame","year":"2000","unstructured":"Nyame, A. K., Leppanen, A. M., Bogitsh, B. J. & Cummings, R. D. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes. Exp Parasitol \n                           96, 202\u2013212, https:\/\/doi.org\/10.1006\/expr.2000.4573 (2000).","journal-title":"Exp Parasitol"},{"key":"16811_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-128","volume":"9","author":"IJ Marques","year":"2009","unstructured":"Marques, I. J. et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC cancer \n                           9, 128, https:\/\/doi.org\/10.1186\/1471-2407-9-128 (2009).","journal-title":"BMC cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16811-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:24:49Z","timestamp":1671805489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["16811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-16811-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]},"assertion":[{"value":"14 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16623"}}